|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/497 | (2013.01) |
| C07D 263/58 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 263/58 | (2013.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| C07D 417/12 | (2013.01) | ||
| C07F 9/6558 | (2006.01) | ||
| C07D 471/04 | (2013.01) | ||
| C07D 215/227 | (2006.01) | ||
| C07F 9/65583 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| C07D 215/227 | (2013.01) | ||
| C07D 401/14 | (2013.01) | ||
| C07D 413/10 | (2013.01) | ||
| C07D 413/14 | (2013.01) | ||
| C07D 417/14 | (2013.01) | ||
| A61K 31/496 | (2013.01) | ||
| C07D 241/04 | (2013.01) | ||
| C07D 215/22 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 25/20 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3309151 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17176623.1 |
| Date of filing the European patent application | 2010-06-24 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 220480 P | 2009-06-25 | US | |
| 293087 P | 2010-01-07 | US |
| (72) |
REMENAR, Julius F. , US
BLUMBERG, Laura Cook , US
ZEIDAN, Tarek A. , US
|
| (73) |
Alkermes Pharma Ireland Limited ,
Connaught House
1 Burlington Road, Dublin 4,
IE
|
| (54) | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS |
| HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS |